Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23620457)

1.

MCP2011--the 7th international conference on multiple comparison procedures.

Wang SJ, Hsu JC, Posch M.

Biom J. 2013 May;55(3):271-4. doi: 10.1002/bimj.201300025. No abstract available.

PMID:
23620457
2.

MCP2009 - 6(th) International Conference on Multiple Comparison Procedures.

Hirotsu C, Posch M, Bretz F.

Biom J. 2010 Dec;52(6):705-7. doi: 10.1002/bimj.201000195. No abstract available.

PMID:
21154894
3.

How to deal with multiple endpoints in clinical trials.

Neuhäuser M.

Fundam Clin Pharmacol. 2006 Dec;20(6):515-23. Review.

PMID:
17109645
4.

Gatekeeping procedures with clinical trial applications.

Dmitrienko A, Tamhane AC.

Pharm Stat. 2007 Jul-Sep;6(3):171-80.

PMID:
17583553
5.
6.

Three methods for constructing parallel gatekeeping procedures in clinical trials.

Dmitrienko A, Soulakova JN, Millen BA.

J Biopharm Stat. 2011 Jul;21(4):768-86. doi: 10.1080/10543406.2011.554130. Review.

PMID:
21516568
7.

Multiple analyses in clinical trials: sound science or data dredging?

Lord SJ, Gebski VJ, Keech AC.

Med J Aust. 2004 Oct 18;181(8):452-4. Review. No abstract available.

PMID:
15487966
8.

Multiple comparisons in complex clinical trial designs.

Hung HM, Wang SJ.

Biom J. 2013 May;55(3):420-9. doi: 10.1002/bimj.201200048. Epub 2013 Feb 18. Review.

PMID:
23620458
9.

Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine.

Millis SR.

Am J Phys Med Rehabil. 2003 Oct;82(10 Suppl):S32-7. Review.

PMID:
14502037
10.

Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures.

Bretz F, Maurer W, Hommel G.

Stat Med. 2011 Jun 15;30(13):1489-501. doi: 10.1002/sim.3988. Epub 2011 Feb 3.

PMID:
21290405
11.

Clinical trials with allergen products--statistical considerations.

Volkers P.

Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):172-80; discussion 181. No abstract available.

PMID:
17393737
12.

The limitations of small outcome studies.

Gibbons RJ, Hodge D.

J Nucl Cardiol. 2012 Apr;19(2):230-2. doi: 10.1007/s12350-012-9521-1. No abstract available.

PMID:
22359226
13.

Testing non-inferiority and superiority for two endpoints for several treatments with a control.

Lawrence J.

Pharm Stat. 2011 Jul-Aug;10(4):318-24. doi: 10.1002/pst.468. Epub 2010 Oct 15.

PMID:
20949636
14.

General theory of mixture procedures for gatekeeping.

Dmitrienko A, Tamhane AC.

Biom J. 2013 May;55(3):402-19. doi: 10.1002/bimj.201100258. Epub 2013 Feb 19.

PMID:
23423821
15.

Challenges to multiple testing in clinical trials.

James Hung HM, Wang SJ.

Biom J. 2010 Dec;52(6):747-56. doi: 10.1002/bimj.200900206.

PMID:
20589856
16.

Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.

Sozu T, Sugimoto T, Hamasaki T.

J Biopharm Stat. 2011 Jul;21(4):650-68. doi: 10.1080/10543406.2011.551329.

PMID:
21516562
17.

What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies.

Song R, Cook TD, Kosorok MR.

J Biopharm Stat. 2008;18(2):370-81. doi: 10.1080/10543400701697224.

PMID:
18327727
18.

SOP 09: Statistical design and analysis.

[No authors listed]

Onkologie. 2003 Oct;26 Suppl 6:43-7. No abstract available.

PMID:
23570186
19.

Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research.

Hommel G, Bretz F, Maurer W.

J Biopharm Stat. 2011 Jul;21(4):595-609. doi: 10.1080/10543406.2011.552879.

PMID:
21516559
20.

On the treatment effect in clinical trials with dropout.

Shao J, Zhong B.

J Biopharm Stat. 2006;16(1):25-33.

PMID:
16440835
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk